Table 1. Participant characteristics.
Participants (n = 31) | |
---|---|
Age | |
Mean | 47.6 |
Range | 29–61 |
Gender | |
Men | 14 (45%) |
Women | 15 (48%) |
Transgender, Two-Spirit, or non-binary | 2 (6%) |
Ethnicity | |
White | 13 (42%) |
Indigenous | 16 (52%) |
Other | 2 (6%) |
Receiving ART | |
Yes | 30 (97%) |
No | 1 (3%) |
Drug of choice | |
Heroin | 11 (35%) |
Crack cocaine | 3 (10%) |
Crystal methamphetamine | 9 (29%) |
Other (e.g., cannabis, powder cocaine) | 8 (26%) |
Frequency of drug use | |
Daily | 16 (52%) |
3–4 times per week | 7 (23%) |
One or fewer times per week | 8 (26%) |
Current ART modela | |
Self-administration | 16 (52%) |
Daily delivery | 7 (23%) |
Daily pickup | 8 (26%) |
Receiving methadone maintenance therapy | |
Yes | 14 (45%) |
No | 17 (55%) |
Social assistance as primary income source | |
Yes | 30 (97%) |
No | 1 (3%) |
a Note participants may have previous experience with treatment models other than that which they currently reported using.